200 related articles for article (PubMed ID: 30969500)
1. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
[No Abstract] [Full Text] [Related]
2. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
Rauer S; Marks R; Urbach H; Warnatz K; Nath A; Holland S; Weiller C; Grimbacher B
N Engl J Med; 2019 Apr; 380(17):1676-1677. PubMed ID: 30969507
[No Abstract] [Full Text] [Related]
3. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
4. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
6. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
7. IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
Guille M; Rousset S; Bonneville F; Mengelle C; Taoufik Y; Delobel P; Martin-Blondel G
AIDS; 2019 Oct; 33(12):1954-1956. PubMed ID: 31490218
[No Abstract] [Full Text] [Related]
8. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
9. Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis.
Taoufik Y; Delfraissy JF; Gasnault J
AIDS; 2000 Apr; 14(6):758-9. PubMed ID: 10807206
[No Abstract] [Full Text] [Related]
10. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Paues J; Vrethem M
J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
[TBL] [Abstract][Full Text] [Related]
11. [The clinical spectrum of progressive multifocal leukoencephalopathy: differences and similarities in patients with and without human immunodeficiency virus].
Camporro J; Bruno V; Cammarota A; Del Castillo M; Alessandro L
Rev Neurol; 2019 Aug; 69(4):152-158. PubMed ID: 31334558
[TBL] [Abstract][Full Text] [Related]
12. Mefloquine in the treatment of progressive multifocal leukoencephalopathy.
Gofton TE; Al-Khotani A; O'Farrell B; Ang LC; McLachlan RS
J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):452-5. PubMed ID: 20562463
[TBL] [Abstract][Full Text] [Related]
13. A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia.
Patel A; Patel J; Ikwuagwu J
J Antimicrob Chemother; 2010 Dec; 65(12):2697-8. PubMed ID: 20864499
[No Abstract] [Full Text] [Related]
14. [A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy].
Ohnuki E; Asayama S; Asayama T; Nakamichi K; Saijo M; Kosaka S
Rinsho Shinkeigaku; 2016 Oct; 56(10):705-708. PubMed ID: 27645758
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy: a confused woman, an ambitious virus and an unusual MRI.
Worthley DL; Sandhu A; Norton G
Intern Med J; 2002; 32(5-6):266-7. PubMed ID: 12036226
[No Abstract] [Full Text] [Related]
16. Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
López Sala P; Alberdi Aldasoro N; Zelaya Huerta MV; Bacaicoa Saralegui MC; Cabada Giadás T
Radiologia (Engl Ed); 2020; 62(1):59-66. PubMed ID: 31375267
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia.
Aung AK; Robinson J; Hey P; Lehmann M; Chow Y; Stark RJ; Bosco JJ
Intern Med J; 2019 Jan; 49(1):114-118. PubMed ID: 30680891
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
[TBL] [Abstract][Full Text] [Related]
20. Subacute visual loss as the sole presenting feature in progressive multifocal leukoencephalopathy.
Kreps EO; Van Hoof A; Reyniers R
Clin Exp Ophthalmol; 2015 Aug; 43(6):599-600. PubMed ID: 25678343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
